Quan Li,* Wen-Xu Jin,* Yi-Xiang Jin, Zhou-Ci Zheng, Xiao-Fen Zhou, Qing-Xuan Wang, Dan-Rong Ye, Yi-Han Sun, Xiao-Hua Zhang, Ou-Chen Wang, En-Dong Chen, Ye-Feng Cai Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China *These authors contributed equally to this work Aim: To investigate the clinical effects of MUC1 on papillary thyroid cancer (PTC) and explore the relationship between MUC1 expression and BRAF mutation. Methods: The data of 69 patients subjected to fine-needle aspiration biopsy in our hospital and 486 patient data downloaded from The Cancer Genome Atlas (TCGA) database were used. Univariate and multivariate analyses were performed.Results: The results on...
Importance: BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PT...
Activating mutations of BRAF have been identified in a variety of human cancers, most notably melano...
Mutational analysis is reshaping the practice of fine-needle aspiration cytology for the diagnosis o...
Haoyu Ren,1 Yifan Shen,2 Daixing Hu,1 Wei He,1 Jing Zhou,1 Yijia Cao,1 Yu Mao,1 Yi Dou,1 Wei Xiong,1...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Background: The BRAF mutation has been shown to be associated with aggressive clinicopathologic char...
Copyright © 2015 Li-Bo Yang et al. This is an open access article distributed under the Creative Com...
Our purpose was to evaluate MUC1 clinical utility in the diagnosis and prognosis of thyroid cancer p...
Our purpose was to evaluate MUC1 clinical utility in the diagnosis and prognosis of thyroid cancer p...
BRAF((V600E)) mutation is the most frequent genetic alteration in papillary thyroid carcinomas (PTCs...
Abstract CONTEXT: Because very few studies have examined the correlation between BRAF mutations an...
clinicopathological parameters i often present with larger tumor size and at a younger age Human Pat...
Abstract Background While some studies suggest that the BRAF V600E mutation correlates with a high-r...
Papillary thyroid cancer (PTC) constitutes more than 90 % of the thyroid cancers. MAP kinase/ERK pat...
Importance: BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PT...
Activating mutations of BRAF have been identified in a variety of human cancers, most notably melano...
Mutational analysis is reshaping the practice of fine-needle aspiration cytology for the diagnosis o...
Haoyu Ren,1 Yifan Shen,2 Daixing Hu,1 Wei He,1 Jing Zhou,1 Yijia Cao,1 Yu Mao,1 Yi Dou,1 Wei Xiong,1...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–90% of all...
Background: The BRAF mutation has been shown to be associated with aggressive clinicopathologic char...
Copyright © 2015 Li-Bo Yang et al. This is an open access article distributed under the Creative Com...
Our purpose was to evaluate MUC1 clinical utility in the diagnosis and prognosis of thyroid cancer p...
Our purpose was to evaluate MUC1 clinical utility in the diagnosis and prognosis of thyroid cancer p...
BRAF((V600E)) mutation is the most frequent genetic alteration in papillary thyroid carcinomas (PTCs...
Abstract CONTEXT: Because very few studies have examined the correlation between BRAF mutations an...
clinicopathological parameters i often present with larger tumor size and at a younger age Human Pat...
Abstract Background While some studies suggest that the BRAF V600E mutation correlates with a high-r...
Papillary thyroid cancer (PTC) constitutes more than 90 % of the thyroid cancers. MAP kinase/ERK pat...
Importance: BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PT...
Activating mutations of BRAF have been identified in a variety of human cancers, most notably melano...
Mutational analysis is reshaping the practice of fine-needle aspiration cytology for the diagnosis o...